Skip to contentP
Prestige Consumer Healthcare Inc.
P
PBHPrestige Consumer Healthcare Inc. Q3 2020 · 10-Q
Revenue$241.55M$241.55M+0.1% vs Q3 2019 Net Income$38.06M$38.06M−0.3% vs Q3 2019 EPS Diluted$0.75$0.75+2.7% vs Q3 2019 Gross Profit$137,495,000−1.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Prestige Consumer Healthcare Inc. · CIK 1295947 · Engraved from SEC EDGAR
Operating Cash Flowderived$57,998,000+33.9% Free Cash Flowderived$54,765,000+32.7% Margins · derivedGross margin56.9%−0.8 pt vs Q3 2019
Operating margin31.6%−0.5 pt vs Q3 2019
Net margin15.8%−0.1 pt vs Q3 2019
ended Dec 31, 2019 · filed Feb 6, 2020 · 37 d after period end